OnKure Therapeutics

Committed to the discovery and development of best-in-class precision medicines that target biologically validated drivers of cancers and vascular anomalies.

[OnKure Therapeutics @OnKureTx]

Join @OnKureTx $OKUR for a virtual KOL event on July 15 at 11am ET with Drs. Cravatt and Abraham to discuss the significance of selectivity and the Company's structure-based design of allosteric pan-mutant PI3Kα inhibitors.

Register: https://t.co/0jYnI98gGE

[OnKure Therapeutics @OnKureTx]

OnKure Announces Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219

https://t.co/wp76OALr2g

[OnKure Therapeutics @OnKureTx]

We are thrilled to announce the closing of our merger with Reneo Pharmaceuticals and concurrent financing!

https://t.co/7bJTaGa5bH

[OnKure Therapeutics @OnKureTx]

Say hello to #OnKure’s newest Research Scientist, Sayali Upasham Lewis. Welcome to the #OnKure team!

[OnKure Therapeutics @OnKureTx]

Meet #OnKure’s new Senior Director of Clinical Operations, Amy Heim, and our new Senior Director Translational Medicine and Biomarkers, Brian Tunquist. Welcome to the #OnKure team!

[OnKure Therapeutics @OnKureTx]

#OnKure’s Senior Vice President, Clinical Pharmacology and DMPK Kevin Litwiler, Ph.D., explains what inspires him to go to work every day.

[OnKure Therapeutics @OnKureTx]

Meet #OnKure’s new Research Scientist of Process Chemistry, Yubai Zhou. Welcome to the #OnKure team!

[OnKure Therapeutics @OnKureTx]

#OnKure has closed a $54 Million Series C Financing to advance the next generation of oncology precision medicines. Read more here: https://t.co/PLgOiEnmYb

[OnKure Therapeutics @OnKureTx]

Skiing has become a beloved tradition outside the #OnKure office to bond as a team and build camaraderie, and we couldn’t ask for a better day to cap off ski season.

[OnKure Therapeutics @OnKureTx]

Thinking about joining the #OnKure team? Check out our recently updated career page and take a look at our open positions here: https://t.co/pRa5FOJRbn

[OnKure Therapeutics @OnKureTx]

This past week, the #OnKure team had an exciting time interacting with the cancer research community in person and discussing the latest advances in cancer medicine. Thank you @AACR for bringing together the best minds in cancer research from all over the world. #AACR23

[OnKure Therapeutics @OnKureTx]

We are reminiscing about our company ski day last week. What’s a better way to celebrate the end of winter than a fun day on the slopes with our #OnKure colleagues?

[OnKure Therapeutics @OnKureTx]

This International Women’s Day, #OnKure celebrates the breakthroughs and accomplishments of women everywhere. We are especially grateful for our female team members that are integral to driving our innovative science forward. #WomeninSTEM #IWD

[OnKure Therapeutics @OnKureTx]

Have you been keeping up with your #sunsafe resolutions? Protecting your skin from the sun is the best way to prevent #melanoma! #NationalCancerPreventionMonth

[Melanoma Research @MelanomaReAlli]

It’s never too late to live your life #sunsafe! Will you join us in committing to sun safety in 2023? #melanoma

[OnKure Therapeutics @OnKureTx]

Meet #OnKure’s new Director of Project Management, Navi Mehra. Welcome to the #OnKure team!

[OnKure Therapeutics @OnKureTx]

#OnKure Therapeutics recognizes #NationalCancerPreventionMonth, an initiative dedicated to helping people reduce their cancer risk by raising awareness of preventable causes. Learn more about #Cancer Prevention on @AACR’s website: https://t.co/owCZ1jpagm

[OnKure Therapeutics @OnKureTx]

Last week, the #OnKure team took to the slopes and had an amazing time skiing together.

[OnKure Therapeutics @OnKureTx]

CMO Jennifer Diamond, M.D., is here to provide information on NRAS-mutated #melanoma. #OnKure has chosen this aggressive melanoma as its first indication for OKI-179, our Class I HDAC inhibitor. #OnKureExplains

[OnKure Therapeutics @OnKureTx]

Wonder what it is like to work at #OnKure? Hear from Yevgeniy Izrayelit, Ph.D., Senior Research Investigator, on how he would describe the work environment.

[OnKure Therapeutics @OnKureTx]

Happy New Year from the #OnKure Team! Wishing you and yours a safe, healthy, and prosperous 2023.